Medtronic MDT
NYSE MDT
$92.43 +0.04 (+0.04%)
As of: Sep 9, 2026 · 12:14 PM EDT

Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026)

Medtronic's (MDT) quarterly Total Non-Current Liabilities came in at $40.5 billion in Q3 2026, down 1.39% year-over-year from $41.0 billion in Q3 2025, and down 1.09% quarter-over-quarter from $40.9 billion in Q2 2026.

Analysis

Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

Medtronic has disclosed Total Non-Current Liabilities across 13 years of filings, most recently posting $40.5 billion for Q3 2026.

  • In Q3 2026, Total Non-Current Liabilities fell 1.39% year-over-year to $40.5 billion; the TTM figure through Jul 2026 stood at $40.5 billion (down 1.39% YoY), while the FY2026 annual figure was $40.9 billion, down 1.81% from the prior year.
  • Total Non-Current Liabilities came in at $40.5 billion for Q3 2026 at Medtronic, down from $40.9 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $41.7 billion in Q2 2025 to a low of $36.2 billion in Q2 2022.
  • Average Total Non-Current Liabilities over 5 years is $38.9 billion, with a median of $39.7 billion recorded in 2024.
  • Year-over-year, Total Non-Current Liabilities fell 16.11% in 2022 and increased 10.48% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $40.8 billion in 2022, then retreated by 10.22% to $36.7 billion in 2023, then increased by 8.53% to $39.8 billion in 2024, then climbed by 2.34% to $40.7 billion in 2025, then retreated by 0.66% to $40.5 billion in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $40.5 billion in Q3 2026, $40.9 billion in Q2 2026, and $40.5 billion in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 184.10 Bn 178.50 Bn 7.27 Bn -
2 Intuitive Surgical 124.21 Bn 118.99 Bn 1.96 Bn 1.92 Bn
3 Medtronic 118.33 Bn 109.51 Bn 6.34 Bn 40.46 Bn
4 Stryker 104.21 Bn 100.73 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 66.39 Bn 65.86 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.69 Bn 45.43 Bn 1.35 Bn 2.57 Bn
7 Alcon 33.94 Bn 32.48 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn 3.68 Bn
9 Steris 21.15 Bn 20.67 Bn 684.20 Mn 3.44 Bn
10 Zimmer Biomet Holdings 18.14 Bn 17.73 Bn 1.54 Bn 9.53 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 40.46 Bn
Apr 24, 2026 40.90 Bn
Jan 23, 2026 40.52 Bn
Oct 24, 2025 40.73 Bn
Jul 25, 2025 41.03 Bn
Apr 25, 2025 41.66 Bn
Jan 24, 2025 38.83 Bn
Oct 25, 2024 39.79 Bn
Jul 26, 2024 39.67 Bn
Apr 26, 2024 37.70 Bn
Jan 26, 2024 37.02 Bn
Oct 27, 2023 36.66 Bn
Jul 28, 2023 37.00 Bn
Apr 28, 2023 36.92 Bn
Jan 27, 2023 40.21 Bn
Oct 28, 2022 40.84 Bn
Jul 29, 2022 36.88 Bn
Apr 29, 2022 36.17 Bn
Jan 28, 2022 36.98 Bn
Oct 29, 2021 39.33 Bn